Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Budesonide Metabolism in Women
NCT03537326Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- May 2018
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of budesonide in Crohn's disease, sponsored by Parc de Salut Mar. Primary endpoint: Urine concentration of 6beta-hydroxy-budesonide. Started May 2018; status: completed.
02
Drugs
budesonide
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT03537326.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03537326.